Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2001, p. 2134-2135, Vol. 45, No. 7
Division of Gastroenterology, Department of
Pediatrics,1 and Department of
Microbiology,2 Hôpital Saint Vincent de
Paul, 75674 Paris Cedex 14, and Department of Pediatrics,
Hôpital Saint Antoine, Université Catholique de Lille,
59000 Lille,3 France
Received 28 November 2000/Returned for modification 23 January
2001/Accepted 13 April 2001
Outcome of Helicobacter pylori infection was analyzed
in 61 children treated with a triple therapy including clarithromycin. Bacterial eradication was obtained in all children with
clarithromycin-susceptible strains but not in children with
clarithromycin-resistant ones (P = 0.0001). H. pylori antimicrobial susceptibility is mandatory before choosing
a treatment, and clarithromycin should be avoided in case of resistance.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2134-2135.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Clarithromycin Resistance and Eradication of
Helicobacter pylori in Children
*
Corresponding author. Mailing address: Department of
Microbiology, Hôpital Saint Vincent de Paul, 82, Avenue Denfert
Rochereau, 75674 Paris Cedex 14, France. Phone: (33) 1-40 48 81 11. Fax: (33) 1-40 48 83 18. E-mail:
j.raymond{at}svp.ap-hop-paris.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»